Company press releases

Displaying 151 - 200 of 214 results
Released Company Title Industry Topic
14 Feb 2025
19:00 CET 		OXURION Oxurion strengthens its Board of Directors with the arrival of Nelly Souleymane 20103010 Biotechnology Legal
14 Feb 2025
19:00 CET 		OXURION Oxurion renforce son Conseil d'Administration avec l'arrivée de Nelly Souleymane 20103010 Biotechnology Legal
14 Feb 2025
19:00 CET 		OXURION Oxurion versterkt zijn Raad van Bestuur met de komst van Nelly Souleymane 20103010 Biotechnology Legal
20 Jan 2025
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
20 Jan 2025
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Jan 2025
18:00 CET 		OXURION Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Jan 2025
18:00 CET 		OXURION Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
13 Jan 2025
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
06 Jan 2025
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
06 Jan 2025
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
03 Jan 2025
18:00 CET 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
31 Dec 2024
18:00 CET 		OXURION Oxurion annonce le report de la signature de la transaction stratégique en raison de discussions en cours 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
31 Dec 2024
18:00 CET 		OXURION Oxurion Announces Postponement of Signing for Strategic Transaction Due to Ongoing Discussions 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
31 Dec 2024
18:00 CET 		OXURION Oxurion kondigt uitstel aan van ondertekening van strategische transactie wegens lopende besprekingen 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
19 Dec 2024
18:00 CET 		OXURION French Authorities Approve Oxurion's Strategic Transaction Under Specific Conditions 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
19 Dec 2024
18:00 CET 		OXURION Les autorités françaises approuvent la transaction stratégique d'Oxurion, sous certaines conditions spécifiques 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
19 Dec 2024
18:00 CET 		OXURION Franse autoriteiten keuren de strategische transactie van Oxurion goed onder specifieke voorwaarden 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
12 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
12 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
09 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
09 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
05 Dec 2024
18:00 CET 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
05 Dec 2024
18:00 CET 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
04 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
04 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
02 Dec 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
02 Dec 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
28 Nov 2024
19:00 CET 		OXURION Oxurion annonce que son acquisition potentielle est soumise au contrôle des investissements étrangers 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
28 Nov 2024
19:00 CET 		OXURION Oxurion announces that its potential acquisition is subject to foreign investment control 20103010 Biotechnology Alliances and agreements, Mergers, Acquisitions, Transfers
14 Nov 2024
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Nov 2024
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
05 Nov 2024
10:30 CET 		OXURION Oxurion met fin à sa procédure de réorganisation judiciaire privée à la suite d'accords de règlement à l'amiable 20103010 Biotechnology Legal
05 Nov 2024
10:30 CET 		OXURION Oxurion beëindigt haar privé gerechtelijke reorganisatieprocedure na minnelijke schikkingen 20103010 Biotechnology Legal
05 Nov 2024
10:30 CET 		OXURION Oxurion terminates its Private Judicial Reorganization Procedure following amicable settlement agreements 20103010 Biotechnology Legal
29 Oct 2024
22:00 CET 		OXURION Oxurion NV : Principales évolutions et calendrier concernant l'acquisition potentielle en cours 20103010 Biotechnology Other subject
29 Oct 2024
22:00 CET 		OXURION Oxurion NV: Key developments and timeline for current the potential acquisition 20103010 Biotechnology Other subject
29 Oct 2024
22:00 CET 		OXURION Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname 20103010 Biotechnology Other subject
24 Oct 2024
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
24 Oct 2024
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Oct 2024
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
14 Oct 2024
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital
10 Oct 2024
18:00 CEST 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
10 Oct 2024
18:00 CEST 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
02 Oct 2024
18:00 CEST 		OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC 20103010 Biotechnology Change in Capital